Quantcast

Latest Tissue plasminogen activator Stories

2011-07-01 12:36:41

African-Americans are less likely than whites to receive critical stroke treatment primarily because they do not get to a hospital soon enough for time-sensitive treatment and because of preexisting medical conditions. For patients who are eligible for treatment, no racial disparity was found. Those are the findings of a new Georgetown University Medical Center study involving the review of almost 1,000 patient records from all seven acute care hospitals in Washington, DC. The new study will...

2011-06-03 12:34:55

American Heart Association rapid access journal report The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 "” but is still low, according to research reported in Stroke: Journal of the American Heart Association. Clot-busting drugs are known as thrombolytics, and tissue plasminogen activator (tPA) is the only FDA-approved thrombolytic for treating acute ischemic stroke, which is caused by a blood clot in the brain. Although the study didn't...

2011-05-27 21:43:17

Treatment for stroke subset reduces mortality, improves quality of life A new treatment that treats a subset of stroke patients by combining minimally invasive surgery, an imaging technique likened to "GPS for the brain," and the clot-busting drug t-PA appears to be safe and effective, according to a multicenter clinical trial led by Johns Hopkins researchers. The novel treatment, detailed for the first time at this week's European Stroke Conference in Hamburg, Germany, was developed for...

2011-05-18 14:16:27

Strokes are not typically thought of as a childhood health issue, but Baylor College of Medicine experts warn that they do occur in children and can result in significant long-lasting effects. "The incidence of strokes occurring in children is similar to that of pediatric brain tumors," said Dr. Lisa Nassif, assistant professor of pediatrics and neurology at BCM and pediatric neurologist at Texas Children's Hospital. "The more that people become aware that strokes can in fact happen in...

2011-05-10 13:14:19

Approximately 14 percent of all strokes occur during sleep, preventing many from getting clot-busting treatment, according to a study published in the May 10, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. "Because the only treatment for ischemic stroke must be given within a few hours after the first symptoms begin, people who wake up with stroke symptoms often can't receive the treatment since we can't determine when the symptoms...

2011-05-10 08:02:32

(Ivanhoe Newswire) -- Approximately 14 percent of all strokes occur during sleep, preventing many from getting clot-busting treatment, according to a study. "Because the only treatment for ischemic stroke must be given within a few hours after the first symptoms begin, people who wake up with stroke symptoms often can't receive the treatment since we can't determine when the symptoms started," study author Jason Mackey, M.D., of the University of Cincinnati and a member of the American...

2011-05-02 10:00:00

CENTENNIAL, Colo., May 2, 2011 /PRNewswire/ -- Bailey Carlson, 17, appears to live a typical teenage life. She is focused on school, friends and sleepovers. Like many teens, she has days when all she wants is to feel "normal." But Bailey faces something on a daily basis that most would never imagine: recovery from stroke. While stroke-a leading cause of death and adult disability-might seem out of the ordinary for a teen, the reality is that it affects all ages. It is also up to 80...

2011-03-19 00:00:28

Dr. George Rappard's Site is cleared to begin enrolling patients in new study. This clinical trial is the first U.S. study involving the use of the patient's own stem cells, infused into the brain as a regenerative therapy, two weeks after a stroke. Los Angeles, CA (PRWEB) March 18, 2011 The Los Angeles Brain and Spine Institute, directed by George Rappard, is the first to study brain stem cell infusion as a stroke treatment. The trial will be conducted using using Aldagen Inc's ALD-401, a...

2011-03-15 09:15:00

DALLAS, March 15, 2011 /PRNewswire/ -- Children's Medical Center Dallas (Children's) http://childrens.com is launching a critical stroke initiative to diagnose and treat strokes in children. Pediatric strokes is a little-known condition that occurs as often as leukemia and brain tumors but often is not recognized by parents or physicians, despite the serious short- and long-term health consequences. As part of this effort, Children's will be one of four research sites in North America...

2011-03-03 13:35:00

RESEARCH TRIANGLE PARK, N.C., March 3, 2011 /PRNewswire/ -- Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related